Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daria G Valerio

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Cell|April 13, 2016
Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression ProgramsGerard L Brien, Daria G Valerio, Scott A Armstrong
Blood|November 10, 2016
Histone acetyltransferase activity of MOF is required for adult but not early fetal hematopoiesis in miceDaria G Valerio, Haiming Xu, Meghan E Eisold, et al.
Haematologica|May 13, 2014
Mapping epigenetic regulator gene mutations in cytogenetically normal pediatric acute myeloid leukemiaDaria G Valerio, Jenny E Katsman-Kuipers, Joop H Jansen, et al.
Cancer Cell|November 28, 2016
NUP98 Fusion Proteins Interact with the NSL and MLL1 Complexes to Drive LeukemogenesisHaiming Xu, Daria G Valerio, Meghan E Eisold, et al.
Cancer Research|February 17, 2017
Histone Acetyltransferase Activity of MOF Is Required for <i>MLL-AF9</i> LeukemogenesisDaria G Valerio, Haiming Xu, Chun-Wei Chen, et al.
Trials|June 19, 2026
CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortiumGertjan J L Kaspers, Merlijn van Hamel, Jonas Abrahamsson, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Cell|April 13, 2016
Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression ProgramsGerard L Brien, Daria G Valerio, Scott A Armstrong
Blood|November 10, 2016
Histone acetyltransferase activity of MOF is required for adult but not early fetal hematopoiesis in miceDaria G Valerio, Haiming Xu, Meghan E Eisold, et al.
Haematologica|May 13, 2014
Mapping epigenetic regulator gene mutations in cytogenetically normal pediatric acute myeloid leukemiaDaria G Valerio, Jenny E Katsman-Kuipers, Joop H Jansen, et al.
Cancer Cell|November 28, 2016
NUP98 Fusion Proteins Interact with the NSL and MLL1 Complexes to Drive LeukemogenesisHaiming Xu, Daria G Valerio, Meghan E Eisold, et al.
Cancer Research|February 17, 2017
Histone Acetyltransferase Activity of MOF Is Required for <i>MLL-AF9</i> LeukemogenesisDaria G Valerio, Haiming Xu, Chun-Wei Chen, et al.
Trials|June 19, 2026
CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortiumGertjan J L Kaspers, Merlijn van Hamel, Jonas Abrahamsson, et al.
Pageof 1